Herpangina Treatment Market Forecast To Reach $2.87 Billion By 2030: Key Trends Explained
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Herpangina Treatment Market CAGR Outlook And Future Development
The market size for herpangina treatment has experienced robust expansion in recent years. This market is projected to expand from $1.96 billion in 2025 to $2.1 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this growth has been fueled by factors such as the rising incidence of viral infections in children, the absence of specific antiviral medications, enhanced awareness in pediatric healthcare, frequent seasonal outbreaks, and restricted healthcare access in rural regions.
The herpangina treatment market size is projected to experience substantial expansion in the coming years, with an expectation to reach $2.87 billion by 2030, displaying a compound annual growth rate (CAGR) of 8.1%. The increase over the forecast period is attributable to the wider adoption of telehealth solutions, advancements in pain management therapies, a rise in homecare uptake, the creation of child-friendly formulations, and growing utilization of over-the-counter (OTC) medications. Key trends for this period include the development of pediatric telemedicine services, the introduction of symptomatic relief formulations, heightened awareness regarding viral infection management, the integration of homecare monitoring devices, and an increase in OTC pain relief products.
Get A Free Sample Report With In-Depth Market Insights:
Herpangina Treatment Market Growth Momentum: What Factors Are Shaping Demand?
An escalating number of research and development initiatives is projected to boost the growth of the herpangina treatment market moving forward. Herpangina is a viral ailment primarily affecting young individuals, causing painful sores or ulcers on the tonsils and at the back of the throat, attributable to coxsackievirus and enteroviruses. Herpangina therapy aims to diminish the severity of symptoms such as blisters, high fever, discomfort in the mouth or throat, drooling, and diminished appetite. For example, in January 2024, data from the New Drug Therapy Approvals 2023 report, issued by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), showed that CDER authorized 55 new drugs in 2023, with 20 (36%) being designated as first-in-class, compared to 37 novel drug approvals in 2022. Thus, the growing volume of research and development activities is fueling the expansion of the herpangina treatment market.
Herpangina Treatment Market Segments: Where Is Growth Concentrated?
The herpangina treatment market covered in this report is segmented –
1) By Treatment: Topical Anesthetics, Ibuprofen Or Acetaminophen, Other Treatments
2) By Virus: Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus
3) By Symptoms: High Fever, Sore Throat, Blisters Or Ulcers In The Throat Mouth, Difficulty Swallowing, Loss Of Appetite, Neck Pain, Swollen Lymph Glands, and Headache
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Herpangina Treatment Market Key Participants And Competitive Landscape
Major companies operating in the herpangina treatment market are Cipla Inc., Dr. Reddys Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Zydus Cadila, Aurobindo Pharma Ltd., Lupin Limited, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Mucocort, Aurena Laboratories AB, CSL Limited, Bayer AG, Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim International GmbH, Pfizer Inc, Eli Lilly and Company
View The Full Herpangina Treatment Market Report:
Herpangina Treatment Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the global herpangina treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herpangina treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
